| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | — | +3.2% |
| Cost of Revenue | $1.3M | — | +5.5% |
| Gross Profit | $2.6M | — | +2.1% |
| R&D Expense | $792K | — | -26.2% |
| SG&A Expense | $711K | — | -9.5% |
| Operating Income | -$171K | — | +66.5% |
| Pre-tax Income | -$81K | — | +87.1% |
| Income Tax | $5K | — | +0.0% |
| Net Income | -$86K | — | +86.4% |
| EPS (Basic) | -$0.01 | — | +83.3% |
| EPS (Diluted) | -$0.01 | — | +83.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.5M | -8.9% | -0.1% |
| Accounts Receivable | $1.6M | +3.1% | +35.9% |
| Current Assets | $3.7M | +6.1% | +18.0% |
| Total Assets | $15.7M | +2.7% | +1.2% |
| Current Liabilities | $5.2M | +4.9% | +2.9% |
| Long-term Debt | $236K | -27.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$39K | — | -121.9% |
| Capital Expenditures | $7K | — | +40.0% |
| Investing Cash Flow | -$17K | — | -240.0% |
| Free Cash Flow | -$46K | — | -126.6% |
| -42.3% |
| Total Liabilities | $6.2M | +7.4% | +3.1% |
| Stockholders' Equity | $9.6M | -0.1% | +0.0% |